Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets closed
Straits Times Index
3,280.10
-7.65
(-0.23%)
Nikkei
37,934.76
+306.28
(+0.81%)
Hang Seng
17,651.15
+366.61
(+2.12%)
FTSE 100
8,139.83
+60.97
(+0.75%)
Bitcoin USD
63,007.90
-1,289.19
(-2.01%)
CMC Crypto 200
1,304.48
-92.06
(-6.59%)
Axsome Therapeutics, Inc. (AXSM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
71.71
+0.19
(+0.27%)
At close: 04:00PM EDT
72.25
+0.54
(+0.75%)
After hours:
06:48PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
270,600
270,600
50,037
0
0
Cost of revenue
26,065
26,065
5,198
0
0
Gross profit
244,535
244,535
44,839
0
0
Operating expenses
Research development
97,944
97,944
57,947
58,061
70,245
Selling general and administrative
323,123
323,123
159,254
66,646
28,897
Total operating expenses
427,442
427,442
221,340
124,707
99,088
Operating income or loss
-182,907
-182,907
-176,501
-124,707
-99,088
Interest expense
6,453
6,453
7,335
5,696
2,566
Total other income/expenses net
-48,918
-48,918
-3,298
-
-1,247
Income before tax
-238,278
-238,278
-187,134
-130,403
-102,901
Income tax expense
960
960
0
0
-
Income from continuing operations
-239,238
-239,238
-187,134
-130,403
-102,901
Net income
-239,238
-239,238
-187,134
-130,403
-102,901
Net income available to common shareholders
-239,238
-239,238
-187,134
-130,403
-102,901
Basic EPS
-4.57
-5.27
-4.60
-3.47
-2.77
Diluted EPS
-4.57
-5.27
-4.60
-3.47
-2.77
Basic average shares
44,457
45,425
40,656
37,619
37,207
Diluted average shares
44,457
45,425
40,656
37,619
37,207
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.